Malin stock analysis
Malin (0Y71) Share Price & Analysis
0Y71 Stock Chart & Stats
- Day’s Range
- EUR 8.60 - EUR 8.60
- 52-Week Range
- EUR 8.60 - EUR 8.60
- Previous Close
- EUR 8.60
- Volume
- N/A
- Average Volume (3M)
- 0
- Market Cap
- EUR 26.07M
- Enterprise Value
- EUR 20.43M
- Total Cash (Recent Filing)
- N/A
- Total Debt (Recent Filing)
- EUR 72.20M
- Price to Earnings (P/E)
- 253.2
- Beta
- 5.14
- Next Earnings
- Mar 04, 2027 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
0Y71 FAQ
What was Malin’s price range in the past 12 months?
What is Malin’s market cap?
When is Malin’s upcoming earnings report date?
How were Malin’s earnings last quarter?
Is Malin overvalued?
Does Malin pay dividends?
What is Malin’s EPS estimate?
How many shares outstanding does Malin have?
What happened to Malin’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Malin?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Malin
Malin Corporation plc operates as a life sciences firm across Ireland and the United States, primarily through its various subsidiaries. The company specializes in developing and delivering vital solutions for critical medical challenges. Its portfolio includes groundbreaking cell and gene therapies aimed at patients with significant unmet medical requirements. Furthermore, Malin provides treatments targeting pressing needs in oncology, infectious diseases, and autoimmune conditions. It also addresses specific women's health concerns, such as recurrent vulvovaginal candidiasis, and offers remedies for fungal nail infections like onychomycosis. Beyond these, Malin's offerings extend to pharmaceutical products for protein misfolding disorders, a sophisticated platform designed to identify pathogenic bacteria within the gut microbiome, and advanced UV-light disinfection technologies. Additionally, it offers corporate secretarial services. Established in 2014, Malin Corporation plc maintains its headquarters in Dublin, Ireland.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Fiona Dunlevy
- Employees
- 2
- Website
- malinplc.com
- Address
- The Lennox Building, Dublin, DU, D02 FK02, IE
Malin (0Y71) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 7 | 3 | 4 |
| Technical Analysis | 1 | 1 | 0 |
| Moving Averages | 6 | 2 | 4 |









